143 related articles for article (PubMed ID: 26455088)
1. Lingering Lyme.
Moyer MW
Sci Am; 2015 Sep; 313(3):16-8. PubMed ID: 26455088
[No Abstract] [Full Text] [Related]
2. [Borrelia burgdorferi--a unique bacterium].
Brorson Ø
Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2114-7. PubMed ID: 19855450
[No Abstract] [Full Text] [Related]
3. Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.
Feng J; Shi W; Zhang S; Zhang Y
Emerg Microbes Infect; 2015 Aug; 4(8):e51. PubMed ID: 26421273
[No Abstract] [Full Text] [Related]
4. Treatment of Lyme disease.
Med Lett Drugs Ther; 2016 May; 58(1494):57-8. PubMed ID: 27148921
[No Abstract] [Full Text] [Related]
5. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
[No Abstract] [Full Text] [Related]
7. Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.
Mosel MR; Carolan HE; Rebman AW; Castro S; Massire C; Ecker DJ; Soloski MJ; Aucott JN; Eshoo MW
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036693
[No Abstract] [Full Text] [Related]
8. The Clinical Relevance of Studies on Borrelia burgdorferi Persisters.
Baker PJ; Wormser GP
Am J Med; 2017 Sep; 130(9):1009-1010. PubMed ID: 28502813
[No Abstract] [Full Text] [Related]
9. Lyme disease: scratching the surface.
Phillips SE; Harris NS; Horowitz R; Johnson L; Stricker RB
Lancet; 2005 Nov; 366(9499):1771. PubMed ID: 16298211
[No Abstract] [Full Text] [Related]
10. Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha.
Stricker RB; Johnson L
J Infect Dis; 2008 May; 197(9):1352-3. PubMed ID: 18422450
[No Abstract] [Full Text] [Related]
11. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice, after antibiotic treatment.
Liegner KB
J Infect Dis; 2003 May; 187(10):1676; author reply 1676. PubMed ID: 12721952
[No Abstract] [Full Text] [Related]
12. Update on lyme disease: the hidden epidemic.
Savely VR
J Infus Nurs; 2008; 31(4):236-40. PubMed ID: 18641487
[TBL] [Abstract][Full Text] [Related]
13. Erythromycin resistance in Borrelia burgdorferi.
Terekhova D; Sartakova ML; Wormser GP; Schwartz I; Cabello FC
Antimicrob Agents Chemother; 2002 Nov; 46(11):3637-40. PubMed ID: 12384380
[TBL] [Abstract][Full Text] [Related]
14. Lyme disease: recent advances and perspectives.
Petnicki-Ocwieja T; Brissette CA
Front Cell Infect Microbiol; 2015; 5():27. PubMed ID: 25883907
[No Abstract] [Full Text] [Related]
15. Chronic Lyme disease: the controversies and the science.
Lantos PM
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):787-97. PubMed ID: 21810051
[TBL] [Abstract][Full Text] [Related]
16. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.
Steere AC; Angelis SM
Arthritis Rheum; 2006 Oct; 54(10):3079-86. PubMed ID: 17009226
[No Abstract] [Full Text] [Related]
17. Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease.
Van Laar TA; Hole C; Rajasekhar Karna SL; Miller CL; Reddick R; Wormley FL; Seshu J
Microbes Infect; 2016 Jun; 18(6):430-435. PubMed ID: 26993029
[TBL] [Abstract][Full Text] [Related]
18. An appraisal of "chronic Lyme disease".
Maloney EL
N Engl J Med; 2008 Jan; 358(4):428-9; author reply 430-1. PubMed ID: 18219748
[No Abstract] [Full Text] [Related]
19. Molecular characterization of Borrelia burgdorferi from case of autochthonous Lyme arthritis.
Brummitt SI; Barbour AG; Hue F; Kjemtrup AM
Emerg Infect Dis; 2014 Dec; 20(12):2168-70. PubMed ID: 25423131
[No Abstract] [Full Text] [Related]
20. Anti-tumor necrosis factor-alpha treatment for Lyme borreliosis.
McSweegan E
J Infect Dis; 2007 Dec; 196(12):1866; author reply 1866-7. PubMed ID: 18190271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
